Corrigendum to “Protective effect of hsa‐miR‐570‐3p targeting CD274 on triple negative breast cancer by blocking PI3K/AKT/mTOR signaling pathway” [Kaohsiung J Med Sci. 2020;36(8):581–591]

Affiliations

Li‐Li Wang: Department of Medical Oncology Fujian Cancer Hospital & Fujian Medical University Cancer Hospital Fuzhou Fujian Province China
Wei‐Wei Huang: Department of Medical Oncology Fujian Cancer Hospital & Fujian Medical University Cancer Hospital Fuzhou Fujian Province China
Jing Huang: Department of Pharmacy Fujian Cancer Hospital & Fujian Medical University Cancer Hospital Fuzhou Fujian Province China
Rong‐Fang Huang: Department of Pathology Fujian Cancer Hospital & Fujian Medical University Cancer Hospital Fuzhou Fujian Province China
Na‐Ni Li: Department of Medical Oncology Fujian Cancer Hospital & Fujian Medical University Cancer Hospital Fuzhou Fujian Province China
Yi Hong: Department of Medical Oncology Fujian Cancer Hospital & Fujian Medical University Cancer Hospital Fuzhou Fujian Province China
Mu‐Lan Chen: Department of Medical Oncology Fujian Cancer Hospital & Fujian Medical University Cancer Hospital Fuzhou Fujian Province China
Fan Wu: Department of Medical Oncology Fujian Cancer Hospital & Fujian Medical University Cancer Hospital Fuzhou Fujian Province China
Jian Liu: Department of Medical Oncology Fujian Cancer Hospital & Fujian Medical University Cancer Hospital Fuzhou Fujian Province China

Abstract

No abstracts available.